Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950129-97-003364
Filing Date
1997-08-14
Accepted
1997-08-14 00:00:00
Documents
4
Period of Report
1997-06-30
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 TEXAS BIOTECHNOLOGY CORPORATION- 6/30/97 10-Q 98333
2 AMENDMENT TO THE 1995 STOCK OPTION PLAN EX-10.62 783
3 AMEND. TO THE 1995 NON-EMPLOYEE DIR. STOCK OPTION EX-10.63 4395
4 FINANCIAL DATA SCHEDULE EX-27 2056
  Complete submission text file 0000950129-97-003364.txt   107313
Mailing Address
Business Address DOCTORS CENTER 7000 FANNIN STE 1920 HOUSTON TX 77030 7137968822
TEXAS BIOTECHNOLOGY CORP /DE/ (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20117 | Film No.: 97662537
SIC: 2836 Biological Products, (No Diagnostic Substances)